Company intelligence / Profile preview

DTA Medical

Ownership: Private
Development stage: Commercial

Overview

DTA Medical develops and markets proprietary electromechanical medical devices—most notably a state-of-the-art tool for carbon dioxide micro-injections (CO2) and transdermal insufflation of hyperbaric oxygen. Their "No Pain System" leverages patented technology to deliver therapy with minimal discomfort. The company has five global patents and markets its products in 22 countries[1].

Therapeutic areas: Dermatology
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on DTA Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DTA Medical.

Explore the full profile